Comment on CMS-2026-1255-0001

Summary: AbbVie Inc. supports the proposed rule to establish electronic prior authorization and interoperability standards for prescription drugs, urging CMS to maintain the October 1, 2027, compliance date. The company advocates for additional requirements, including the designation of a transaction facilitator, the prohibition of proprietary payer portals, and the inclusion of pharmacies in API access to improve patient access and reduce administrative burdens.